209 related articles for article (PubMed ID: 25837441)
1. The impact of anti-tuberculous antibiotics and corticosteroids on cytokine production in QuantiFERON-TB Gold In Tube assays.
Clifford V; Zufferey C; Germano S; Ryan N; Leslie D; Street A; Denholm J; Tebruegge M; Curtis N
Tuberculosis (Edinb); 2015 May; 95(3):343-9. PubMed ID: 25837441
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
[TBL] [Abstract][Full Text] [Related]
3. Alternative biomarkers for classification of latent tuberculosis infection status in pregnant women with borderline Quantiferon plus results.
Tesfaye F; Sturegård E; Walles J; Winqvist N; Balcha TT; Karlson S; Mulleta D; Isberg PE; Jansson M; Björkman P
Tuberculosis (Edinb); 2020 Sep; 124():101984. PubMed ID: 32829076
[TBL] [Abstract][Full Text] [Related]
4. The assessment of cytokines in Quantiferon supernatants for the diagnosis of latent TB infection in a tribal population of Melghat, India.
Bapat PR; Husain AA; Daginawala HF; Agrawal NP; Panchbhai MS; Satav AR; Taori GM; Kashyap RS
J Infect Public Health; 2015; 8(4):329-40. PubMed ID: 25824629
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
[TBL] [Abstract][Full Text] [Related]
6. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
7. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.
Tebruegge M; Dutta B; Donath S; Ritz N; Forbes B; Camacho-Badilla K; Clifford V; Zufferey C; Robins-Browne R; Hanekom W; Graham SM; Connell T; Curtis N
Am J Respir Crit Care Med; 2015 Aug; 192(4):485-99. PubMed ID: 26030187
[TBL] [Abstract][Full Text] [Related]
8. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects.
Hur YG; Kang YA; Jang SH; Hong JY; Kim A; Lee SA; Kim Y; Cho SN
J Infect; 2015 Apr; 70(4):346-55. PubMed ID: 25452040
[TBL] [Abstract][Full Text] [Related]
9. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection.
Petrone L; Vanini V; Chiacchio T; Petruccioli E; Cuzzi G; Schininà V; Palmieri F; Ippolito G; Goletti D
Tuberculosis (Edinb); 2018 Jul; 111():147-153. PubMed ID: 30029901
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay.
Kim HC; Jo KW; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Shim TS
Scand J Infect Dis; 2014 Nov; 46(11):763-9. PubMed ID: 25195652
[TBL] [Abstract][Full Text] [Related]
12. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
Sato S; Nagai H
Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
[TBL] [Abstract][Full Text] [Related]
13. IL-1RA in the supernatant of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus is useful for discriminating active tuberculosis from latent infection.
Akashi S; Suzukawa M; Takeda K; Asari I; Kawashima M; Ohshima N; Inoue E; Sato R; Shimada M; Suzuki J; Yamane A; Tamura A; Ohta K; Tohma S; Teruya K; Nagai H
J Infect Chemother; 2021 Apr; 27(4):617-624. PubMed ID: 33317988
[TBL] [Abstract][Full Text] [Related]
14. In vitro QuantiFERON-TB gold antigen specific interleukin-1beta to diagnose TB among HIV-positive subjects.
Prabhavathi M; Ahamed Kabeer BS; Deenadayalan A; Raja A
Tuberculosis (Edinb); 2016 Jan; 96():27-30. PubMed ID: 26786651
[TBL] [Abstract][Full Text] [Related]
15. Interferon gamma release assays for monitoring the response to treatment for tuberculosis: A systematic review.
Clifford V; He Y; Zufferey C; Connell T; Curtis N
Tuberculosis (Edinb); 2015 Dec; 95(6):639-650. PubMed ID: 26515270
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of cytokine levels using QuantiFERON-TB Gold Plus in patients with active tuberculosis.
Suzukawa M; Takeda K; Akashi S; Asari I; Kawashima M; Ohshima N; Inoue E; Sato R; Shimada M; Suzuki J; Yamane A; Tamura A; Ohta K; Tohma S; Teruya K; Nagai H
J Infect; 2020 May; 80(5):547-553. PubMed ID: 32092390
[TBL] [Abstract][Full Text] [Related]
17. A multicentre verification study of the QuantiFERON
Pieterman ED; Liqui Lung FG; Verbon A; Bax HI; Ang CW; Berkhout J; Blaauw G; Brandenburg A; van Burgel ND; Claessen A; van Dijk K; Heron M; Hooghiemstra M; Leussenkamp-Hummelink R; van Lochem E; van Loo IHM; Mulder B; Ott A; Pontesilli O; Reuwer A; Rombouts P; Saegeman V; Scholing M; Vainio S; de Steenwinkel JEM
Tuberculosis (Edinb); 2018 Jan; 108():136-142. PubMed ID: 29523314
[TBL] [Abstract][Full Text] [Related]
18. The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection.
Chen YM; Chen HH; Lai KL; Hung WT; Lan JL; Chen DY
Rheumatology (Oxford); 2013 Apr; 52(4):697-704. PubMed ID: 23264552
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
[TBL] [Abstract][Full Text] [Related]
20. Multiplex analysis of plasma cytokines/chemokines showing different immune responses in active TB patients, latent TB infection and healthy participants.
Yao X; Liu Y; Liu Y; Liu W; Ye Z; Zheng C; Ge S
Tuberculosis (Edinb); 2017 Dec; 107():88-94. PubMed ID: 29050777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
